Category: Uncategorized

2023 Executive Committee Election

The ASPO Nominating Committee presents the following slate of candidates for approval for open Executive Committee positions:

  1. President-Elect (2023-2025)
    Michael Scheurer, Ph.D., M.P.H.Baylor College of Medicine
  2. Director-at-Large (2023-2027)
    Deborah Glueck, PhD, MS – University of Colorado
  3. Director-at-Large (2023-2027)
    Lorna H. McNeill, PhD, MPH – MD Anderson Cancer Center

Towards Achieving Health Equity – ASPO’s 2022 Annual Meeting

Photo by Jon Tyson on Unsplash

March 13-15, 2022
Marriott University Park, Tucson, Arizona

Communities of color, and people who are low-income, rural, LGBTQ+, immigrants, and Indigenous, among others, face disproportionate and inequitable cancer burdens. While advances in prevention and control research have led to improvements in cancer incidence and better survival from cancer overall, U.S. cancer inequities persist, and for some populations, gaps have widened over time. As highlighted in the 45th ASPO meeting in March 2021, there is an increasing acknowledgment for the impact of structural racism and discrimination as fundamental causes of these cancer inequities.

To further advance the productive discussions from the 2021 ASPO meeting, the theme of the 46thASPO meeting will be Towards Achieving Health Equity and will feature novel approaches to addressing cancer health inequities. The program committee was selected for their commitment and expertise in key areas of cancer health inequities. Working closely with the program committee, we organized a thought-provoking meeting to highlight emergent approaches and opportunities to address cancer inequities.

Four symposia are planned on the topics of:

  1. cancer interception: from concept to clinic
  2. innovations in patient navigation: what’s it going to take to achieve cancer equity?
  3. convergence epidemiology: bridging omics with social determinants and structural factors
  4. re-situating cancer control within public health and communities.

This year, we have also planned an additional panel discussion on institutional approaches for addressing diversity, equity, and inclusion, and concurrent sessions on novel approaches of and bias considerations in using electronic health records data in cancer control research, and challenges and successful examples in cancer consortia. The final program is shaping up with prestigious scholars in each of these topics already confirmed.

The call for abstracts will open in September and the highest-scoring abstracts will be selected for oral presentations at the conference and we will have, as usual, best poster awards.

ASPO’s Annual Meeting will be held Sunday, March 13 – Tuesday, March 15 at the Marriott University Park in Tucson, Arizona. The Associate Director and Program Leader Workshop will be held on Sunday, March 12th. More information is available here.


Scarlett Lin Gomez, M.P.H., Ph.D.
2021 ASPO Program Chair
University of California, San Francisco

Steven Patierno, Ph.D.
2021 ASPO Program Chair
Duke University

Microbiome Research in Cancer Prevention Webinar

ASPO Lifestyle Behaviors, Energy Balance, and Chemoprevention SIG Webinar

Microbiome research in cancer prevention

Tuesday, Feb. 11, 2020,  3-4 p.m. EST

To view the webinar visit,

Research into the microbiome has the potential to expand our understanding of the link between diet, lifestyle and chronic disease. In this webinar, the group explored sample collection, data analysis, and the rationale for studying the microbiome and cancer risk and discussed recent findings in this area.

Relationship of diet and lifestyle factors to the human microbiome
Johanna Lampe, PhD, RD, Associate Director, Public Health Sciences Division, Fred Hutch, Research Professor, Epidemiology, University of Washington

Collection and analysis of microbiome samples
Emily Vogtmann, PhD, MPH, Earl Stadtman Investigator, Metabolic Epidemiology Branch, Division of Cancer Epi & Genetics, National Cancer Institute

The microbiome and cancer risk: recent findings
Jiyoung Ahn, PhD, Associate Professor, NYU School of Medicine, Associate Director of Population Science, NYU Perlmutter Cancer Center

2019 Abstract submission closed

44th Annual Meeting of the American Society of Preventive Oncology (ASPO)

March 22-24, 2020, 2019 at the Marriott Tucson University Park, Tucson, Arizona 


Call for Abstracts & Registration now open! Submit an Abstract AND Register at:

(preliminary program  and more info available at this link.  Your 2020 dues must be paid in order to register at the member rate.)  Please share the Call for Abstracts with the attached flyer!

Abstract deadline: November 11, 2019


The program committee, chaired by Tim Rebbeck and Kate Weaver, has developed an extraordinary program:

Symposium 1:  Community Science Initiatives

Graham Colditz, MD, DrPH, Washington University School of Medicine, Reducing  cancer disparities among rural and medically underserved populations

Jennifer Bea, PhD, University of Arizona Cancer Center, Restoring balance in Indian Country

Bruce Rapkin, PhD, Albert Einstein College of Medicine, Aligning health system and community efforts to promote cancer prevention and control.

Linda Ko, PhD, Fred Hutchinson Cancer Research Center, Community-academic partnerships:  best practices, gaps and opportunities.

Karen M. Winkfield, MD, PhD, Wake Forest Baptist Health, #BlackHealthMatters:  Improving cancer care in Winston-Salem, NC.


Symposium 2:  Precision Prevention vs. Population Prevention (Debate),

Speakers:            Sandro Galea, MD, DrPH, Boston University

Muin Khoury, MD, PhD, Centers for Disease Control and Prevention


Symposium 3:  Social and Molecular Influences on Health Disparities

Scarlett Gomez, PhD, MPH, UC – San Francisco, Building infrastructures to study contextual and molecular influences of health disparities:  Application of multilevel social frameworks.

Timothy Rebbeck, PhD, Harvard School of Medicine, Integration of molecular and social factors in understanding cancer disparities.

Camille Ragin, PhD, MPH, Fox Chase Cancer Center, Cancer in the African diaspora: examining social and molecular levels of influence.

Jesse Plascak, PhD, MPH, Rutgers Cancer Institute of New Jersey, Large-scale assessment of social environmental factors for linkage to epigenetic profiles among a cohort of breast cancer survivors.


Symposium 4:  Mind the Gap:  Implementation of Evidence-based Approaches in Cancer Control

Lucy Spalluto, MD, Vanderbilt University, Current lung cancer screening strategies in the Veterans Health Administration

April Oh, PhD, MPH, National Cancer Institute, DCCPS, Speeding uptake of evidence- based interventions into practice:  Lessons learned from the NCI’s SPRINT Program.

Hoda Badr, PhD, Baylor College of Medicine, Down the rabbit hole:  Experiences of an  NCI SPRINT program participant

Melissa Simon, MD, Northwestern University,  Title:  TBD


  • Four proferred paper sessions selected from submitted abstracts
  • Monday night poster session & reception
  • Special events for junior and senior members
  • Sunday evening social event (more info to follow)


Unique Features: At each ASPO meeting, we feature sessions designed for the varying needs of our members such as:

  • Junior & Senior Member Events
  • Associate Director/Program Leader Workshop (March 21-22:  separate registration in addition to ASPO full conference)
  • ASPO Business Meeting
  • ASPO Distinguished Achievement Awardee
  • Joseph Cullen Awardee for work in Tobacco Control
  • American Cancer Society Travel Awards for underrepresented groups
  • Electra Paskett Annual Scholarship Award for pre- or post-doc highest ranking abstract
  • ASPO-sponsored travel awards
  • Advertisements: Purchase an ad in the program advertising your Cancer Center or career openings
  • Exhibitors: Space for exhibitors in the registration area


Please consider being a part of this meeting. For more information about the meeting please go to: